1. Home
  2. CNTA vs LILAK Comparison

CNTA vs LILAK Comparison

Compare CNTA & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • LILAK
  • Stock Information
  • Founded
  • CNTA 2020
  • LILAK 2017
  • Country
  • CNTA United Kingdom
  • LILAK Bermuda
  • Employees
  • CNTA N/A
  • LILAK N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • LILAK Cable & Other Pay Television Services
  • Sector
  • CNTA Health Care
  • LILAK Telecommunications
  • Exchange
  • CNTA Nasdaq
  • LILAK Nasdaq
  • Market Cap
  • CNTA 2.0B
  • LILAK 1.9B
  • IPO Year
  • CNTA 2021
  • LILAK N/A
  • Fundamental
  • Price
  • CNTA $15.67
  • LILAK $9.78
  • Analyst Decision
  • CNTA Strong Buy
  • LILAK Buy
  • Analyst Count
  • CNTA 7
  • LILAK 3
  • Target Price
  • CNTA $23.14
  • LILAK $12.07
  • AVG Volume (30 Days)
  • CNTA 281.0K
  • LILAK 471.3K
  • Earning Date
  • CNTA 11-15-2024
  • LILAK 11-06-2024
  • Dividend Yield
  • CNTA N/A
  • LILAK N/A
  • EPS Growth
  • CNTA N/A
  • LILAK N/A
  • EPS
  • CNTA N/A
  • LILAK N/A
  • Revenue
  • CNTA $6,853,000.00
  • LILAK $4,506,800,000.00
  • Revenue This Year
  • CNTA N/A
  • LILAK $2.30
  • Revenue Next Year
  • CNTA N/A
  • LILAK $3.66
  • P/E Ratio
  • CNTA N/A
  • LILAK N/A
  • Revenue Growth
  • CNTA N/A
  • LILAK N/A
  • 52 Week Low
  • CNTA $5.58
  • LILAK $5.95
  • 52 Week High
  • CNTA $17.59
  • LILAK $10.93
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 52.05
  • LILAK 54.27
  • Support Level
  • CNTA $14.48
  • LILAK $9.60
  • Resistance Level
  • CNTA $15.64
  • LILAK $9.86
  • Average True Range (ATR)
  • CNTA 0.67
  • LILAK 0.25
  • MACD
  • CNTA -0.11
  • LILAK 0.00
  • Stochastic Oscillator
  • CNTA 55.87
  • LILAK 66.46

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: